RCT
[대역어] RCT
[용어속성] Term
[용어속성] Term
Map the apps: a rapid review of digital approaches to support the engagement of older adults in strength and balance exercises
Research Article
[키워드] accompany
activity
age
approach
Apps
balance
Behaviour change techniques
conducted
COVID-19
COVID-19 pandemic
criteria
database
Digital
effective
Effectiveness
engage
evaluate
evaluated
Evidence
exercise
Falls prevention
Google
identify
independent
information
Map
offer
Older
performed
RCT
reduce
reduced
Result
risk
searched
strength
Support
website
Websites
[DOI] 10.1186/s12877-020-01880-6 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12877-020-01880-6 PMC 바로가기 [Article Type] Research Article
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Meta-Analysis
Published on
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 임상, 진단,
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 임상, 진단,
[키워드] 95%CI
adjusted
adjusted RR
adverse event
approach
association
certainty of evidence
citation
Cohort
cohort study
cohorts
concerning
Controlled
COVID-19
COVID-19 patients
COVID-19 severity
Daily
death
did not reduce
Efficacy
elevated
eligibility criteria
eligible
evaluate
evaluated
Evidence
examined
FIVE
Google
higher risk
hospitalized COVID-19 patients
IL-6
IL-6 receptor
Infection
interleukin-6
lower mortality
mechanical ventilation
Meta-analysis
moderate
Mortality
Multiorgan
objective
observational study
observé
Other
OVID
participant
Patient
patients
Placebo
Randomized controlled trial
RCT
RCTs
reduce
Result
risk
risk of bia
Risk of bias
risk ratio
RRs
severe coronavirus disease
Standard of care
syndrome
systematic review
Tocilizumab
Toxicity
treat
Treatment
Web of Science
while
[DOI] 10.1016/j.cmi.2020.10.036 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1016/j.cmi.2020.10.036 PMC 바로가기 [Article Type] Meta-Analysis
Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] β-cyclodextrin
1:1
absence
anticipated
Antiviral
antivirals
Arm
blinded
Breastfeeding
center
change
citrox®
clinic
clinical
Clinical sign
clinical trial
Complete
composed
conducted
Control
control group
COVID-19
criteria
detection
Diagnosis
dissemination
element
eligibility
Endocarditis
Evolution
France
French
hospital
include
Infection
Infirmary
Intervention
investigator
laboratory technician
lack
less
Mouthwash
mouthwashe
nasal
Nasal sample
number
Nurse
objective
outcome
Parallel Arm
participant
Participants
Patient
PCR assay
performed
Placebo
protocol
question
random
randomisation
randomised
randomised controlled trial
RCT
Registered
reported
risk
Roux
salivary
salivary and real-time PCR
Sample size
SARS-CoV 2
SARS-CoV-2
SARS-CoV-2 viral load
SARS-CoV-2 virus
secondary
Standard
status
study groups
Study protocol
supplementary material
the SARS-CoV-2
Trial
understanding
Viral load
website
[DOI] 10.1186/s13063-020-04846-6 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04846-6 PMC 바로가기 [Article Type] Letter
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence
SARS-CoV-2 약리학적 치료법 및 근거 수준에 따른 안전성/유효성
Review
[키워드] Antiviral
article
Chloroquine
Cochrane Library
COVID-19
COVID-19 clinical outcomes
COVID-19 pharmacologic treatments
COVID-19 transmission
criteria
Dexamethasone
drug
Drug effectiveness
Drug safety
effective
Effectiveness
English
evaluate
Evidence
HCQ
Hydroxychloroquine
include
interferon
interferon beta
Interferon beta-1b
JAMA
level 1
Lopinavir
Lopinavir-ritonavir
Meta-analysis
Mild
mild to moderate
mild to moderate disease
moderate disease
Mortality
network
peer-reviewed
peer-reviewed study
pharmacologic treatment
pharmacologic treatments
plasma
plasma therapy
PNAS
Prognosis
RCT
RCTs
reduced
regimen
Remdesivir
respiratory
Respiratory Support
Result
ribavirin
Ritonavir
SARS-CoV-2
searched
severe disease
significantly
study inclusion
systematic review
Therapies
therapy
Vaccine
[DOI] 10.1016/j.ajem.2020.08.091 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.ajem.2020.08.091 PMC 바로가기 [Article Type] Review
COVID-19 randomized controlled trials in medRxiv and PubMed
medRxiv 및 PubMed의 COVID-19 무작위 대조 시험
Article
[키워드] COVID-19
investigated
medRxiv
Randomized controlled trial
RCT
Spin
[DOI] 10.1016/j.ejim.2020.09.019 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ejim.2020.09.019 PMC 바로가기 [Article Type] Article
The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19
Editorial
[키워드] acute respiratory distress syndrome
administration
affecting
Anti-inflammatory
antioxidant
Antithrombotic
appear
Ascorbate
ascorbic acid
carried
China
country
COVID-19
Critically ill patient
decrease
decreased mortality
deficiency
Efficacy
effort
elevated
Evidence
functions
greater
group
IMPROVE
include
indicated
Intervention
intravenous
investigation
low-middle-income
monotherapy
Mortality
observational study
optimization
overlap
oxidative stress
Patient
patients with COVID-19
patients with pneumonia
physiological functions
plasma
pleiotropic
Pneumonia
Population
prevention
protocol
Randomized controlled trial
Randomized controlled trials
RCT
RCTs
reduce
Registered
Research
risk factor
Risk factors
role
safety profile
Sepsis
severe coronavirus disease
severe respiratory infections
severely ill patient
severity
significantly
sustained
the disease
translation
Treatment
Trial
trials
Vitamin
Vitamin C
with COVID-19
[DOI] 10.3390/nu12113286 PMC 바로가기 [Article Type] Editorial
[DOI] 10.3390/nu12113286 PMC 바로가기 [Article Type] Editorial
Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial
중증 COVID-19 환자의 회복기 혈장 수혈 요법- 안전성, 효능 및 용량 반응 연구: 2상 무작위 대조 시험 연구 프로토콜의 구조화된 요약
Letter
[키워드] (neutrophil
24 hour
24 hours
allergic
allergic reaction
Antibody titre
Arm
ARMS
automated
blinded
Blinding
body temperature
BSMMU
Care
checked
Clinical improvement
collaboration
collected
comparator
computer
Controlled
Controlled trial
convalescent plasma
COVID-19
creatinine
criteria
CRP
CT scan
deaths
defined
diastolic
discharge
dissemination
Donor
donors
dose
dose response
effective
effective dose
Efficacy
Efficacy and safety
element
ELISA
end point
enrolled
Evidence
evidence of
excluded
expected
FiO2
generate
Health Organization
hospital
Hospital stay
ICU
identify
in-hospital mortality
inclusion criteria
initial
intervention arms
Laboratory
laboratory parameter
Laboratory parameters
Laboratory tests
lactating women
lung
lymphocyte
multi-arm
multicentre
neutralizing antibody
neutrophil
normality
number
objective
open
outcome
Oxford
oxygen
oxygen saturations
PaO2
paO2/fiO2
participant
Participants
Patient
PCR assay
performed
plasma
Plasma transfusion
positive
pregnant
Primary outcome
proportion
protocol
random number table
randomised
Randomized controlled trial
RCT
receive
recorded
recording
recruit
recruited
recruitment
reduction in
required
respiratory
respiratory distress
respiratory rate
respiratory symptoms
room air
RT-PCR
RT-PCR assay
Sample size
sample size calculation
SARS-CoV-2
secondary outcome
serum creatinine
Serum ferritin
Seven
Severe case
severe cases
severe COVID-19
severe COVID-19 patient
severe COVID-19 patients
Severe patient
severe patients
Severe respiratory distress
Sex
SGOT
SGPT
SpO2
sputum
standard care
status
Study protocol
Support
systolic
the patient
therapy
These data
titre
transfusion
Treatment
Trial
university
University of Oxford
ventilator
website
World Health Organization
X-ray
[DOI] 10.1186/s13063-020-04734-z PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04734-z PMC 바로가기 [Article Type] Letter
Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients
COVID19 and Transplantation (R Avery, Section Editor)
[키워드] absence
administration
Anecdotal
anti-IL-1
anti-IL-6
appear
bacterial superinfection
baseline
benefit
canakinumab
Case series
characterized
clinical benefit
clinical experience
cohort study
Colchicine
control group
coronavirus disease
Corticosteroid
COVID-19
CRS
cytokine
Cytokine release syndrome
Deleterious
Efficacy and safety
Evidence
finding
heterogeneity
Hyperinflammatory
immunomodulation
immunomodulatory therapy
Immunosuppression
inhibitor
Interpretation
kidney
lack
limit
management
monoclonal
NLRP3 inflammasome
non-transplant patients
observational study
Patient
pleiotropic
Pneumonia
randomized clinical trial
RCT
recent
recipient
reported
review
Safe
shown
Solid
solid organ transplantation
SOT
survival
therapeutic strategy
tissue damage
Tocilizumab
tocilizumab therapy
Transplant
with COVID-19
[DOI] 10.1007/s40472-020-00306-x PMC 바로가기 [Article Type] COVID19 and Transplantation (R Avery, Section Editor)
[DOI] 10.1007/s40472-020-00306-x PMC 바로가기 [Article Type] COVID19 and Transplantation (R Avery, Section Editor)
Reduning injection combined with western medicine for pneumonia A protocol for systematic review and meta-analysis
3800
[키워드] absorbed
Adverse reactions
affected
bias risk
cardiovascular disease
caused
CBM
Chinese
Chongqing
CNKI
Cochrane Library
Combination
data extraction
database
effective
Efficacy
Efficacy and safety
Ethical approval
Ethics
evaluated
Evidence
Health
incidence
induce
Infrastructure
injection
Injections
life-threatening
literature
Man
Meta-analysis
Mortality
New coronavirus
performed
Pneumonia
protocol
provide
rale
RCT
Reduning injection
Registration
required
Research
Respiratory disease
retrieved
review
risk of bia
SARS-CoV-2
Science
severe cases
significantly
Support
systematic review
TCM
technology
the patient
treat
treated
Treatment
VIP
was used
Web of Science
X-ray
[DOI] 10.1097/MD.0000000000022757 PMC 바로가기 [Article Type] 3800
[DOI] 10.1097/MD.0000000000022757 PMC 바로가기 [Article Type] 3800